Over one million children in this country per year are delivered to women who have used alcohol, tobacco, marijuana, or illicit drugs during pregnancy. This webinar series will explore the biological and environmental factors for mothers, children and families that impact the ultimate development of children affected by prenatal substance exposure and provide an overview of family- and school-based intervention strategies that can promote long-term growth and development of this high-risk population of children.
Drug Use in Pregnancy: Mother and Child
Wednesday, June 28, 2023
12:00 p.m.–1:30 p.m.
A child’s prenatal exposure to maternal substance use during gestation is recognized as one of the most significant barriers to the child’s ultimate healthy development. The direct biological toxicity of the drugs and the social and psychological disarray of the substance-misusing environment ultimately impede the child’s growth and development and pose a grave risk to the child’s overall well-being. This session will address the neurobiological changes that occur in the pregnant woman and the developing fetus as a result of exposure to tobacco, marijuana and illicit drugs and describe maternal and neonatal outcomes in pregnancies complicated by substance misuse.
At the conclusion of this session, participants will be able to:
Describe the neurobiology of tobacco, marijuana and illicit drugs on the dopamine receptor system.
Name three effects of prenatal substance use on pregnancy outcome.
List three effects of prenatal substance exposure on newborn outcome
CHA Education Services
Ira J. Chasnoff, MD, an award-winning author, researcher and lecturer, is president of NTI Upstream and a Professor of Clinical Pediatrics at the University of Illinois College of Medicine in Chicago. He is one of the nation’s leading researchers in the field of child development and the effects of environmental factors on the developmental trajectory of children and adolescents. Dr. Chasnoff’s work encompasses community approaches to the integration of behavioral health services into primary healthcare, the schools, and the other multiple systems that serve children and families. Dr. Chasnoff has served several U.S. presidential administrations on committees and commissions dedicated to organizing and coordinating services for children and families across the nation, and developing policies and procedures for addressing the needs of children at risk from prenatal and postnatal trauma. He also has worked with a wide range of States across the nation and internationally in developing universal outreach and early intervention programs for children and families affected by trauma or substance abuse. Dr. Chasnoff received his medical degree from the University of Texas Health Science Center at San Antonio, which in 1991 awarded him its first Distinguished Alumnus Award. He is the author of numerous research articles regarding the long-term cognitive, behavioral, and learning outcomes of high-risk children, and his article on racial and social class bias in the healthcare system has been cited as a landmark study by the American College of Obstetricians and Gynecologists. Dr. Chasnoff has authored 15 books, which have received numerous awards and one of which has been recognized by The Hague International Court. Dr. Chasnoff’s books explore the biological and environmental factors that impact the ultimate development of high-risk children and presents practical strategies for helping children reach their full potential at home and in the classroom. His newest book, Guided Growth, has received international acclaim for its in-depth discussion of educational and behavioral interventions for children and teens with Fetal Alcohol Spectrum Disorders and early trauma.
This course is provided by Connecticut Hospital Association.